moa glp 1 agonist glp-1_analogs [TUSOM Discovery of GLP-1–Based Drugs for
Description
However, the AUC of the victim drugs were not altered by GLP-1 RA administration in most cases, suggesting that clinically significant DDIs are unlikely to occur
Zhou, M
Switching between GLP1RAs should be individualised to mitigate known adverse effects, in particular, those gastrointestinal in nature
Crit Rev Oncol Hematol
As The New Yorker has observed, the rise of GLP-1s marks a shift not only in medicine but in cultureas appetite-modulating drugs move from treating diabetes toward shaping body ideals, identity, and social aspiration
Obes Med
